The Cellular Tumor Antigen p53 Market size is expected to grow at an annual average of 5% during 2022-2028. Cell tumor antigen p53 (tumor suppressor p53 or phosphoprotein p53 or antigen NY CO 13 or TP53) – The oncoprotein p53, also known as p53, is an isoform of the protein encoded by the TP53 gene. The TP53 gene is the most frequently mutated gene in human cancer, indicating that the TP53 gene plays an important role in preventing cancer formation. Activated p53 binds to DNA and activates the expression of several genes, including the microRNA miR-34a, WAF1/CIP1, and hundreds of other downstream genes encoding p21. p21 binds to the G1-S/CDK (CDK4/CDK6, CDK2 and CDK1) complex (molecules important for G1/S transition in the cell cycle) and inhibits its activity.
(Get 15% Discount on Buying this Report)
A full report of Cellular Tumor Antigen p53 Market is available at: https://orionmarketreports.com/cellular-tumor-antigen-p53-market/85159/
The following segmentation are covered in this report:
By Application
- Ovarian Cancer
- Prostate Cancer
- Brain Cancer
- Others
By Type
- COTI-2
- D-12PGJ3
- APR-246
- ATRN-502
- Cenersen Sodium
- MJ-05
- MX-225
- Others
Company Profile
- Advaxis, Inc.
- American Gene Technologies International Inc.
- Aprea AB
- Cellceutix Corporation
- Critical Outcome Technologies Inc.
- Eleos Inc.
- ORCA Therapeutics B.V.
- OSE Immunotherapeutics
- PCI Biotech Holding ASA
- Quark Pharmaceuticals, Inc.
- Shenzen SiBiono GeneTech Co., Ltd.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Cellular Tumor Antigen p53 Market
- The market share of the global Cellular Tumor Antigen p53 Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Cellular Tumor Antigen p53 Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Cellular Tumor Antigen p53 Market
Scope of the report
The research study analyses the Cellular Tumor Antigen p53 Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Cellular Tumor Antigen p53 Market Report
- What was the Cellular Tumor Antigen p53 Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
- What will be the CAGR of Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the Cellular Tumor Antigen p53 Market was the market leader in 2022?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
